Eight-cycle rituximab therapy resulted in complete remission in primary cutaneous marginal zone lymphoma. [electronic resource]
Producer: 20100614Description: e160-3 p. digitalISSN:- 1873-5835
- Adult
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Agents -- administration & dosage
- Antiviral Agents -- therapeutic use
- Drug Administration Schedule
- Hepatitis B, Chronic -- complications
- Humans
- Immunophenotyping
- Lamivudine -- therapeutic use
- Lymphoma, B-Cell, Marginal Zone -- complications
- Male
- Remission Induction
- Reverse Transcriptase Inhibitors -- therapeutic use
- Rituximab
- Skin Neoplasms -- complications
No physical items for this record
Publication Type: Case Reports; Letter; Review
There are no comments on this title.
Log in to your account to post a comment.